BTL, a global leader in non-invasive medical solutions, proudly announces expanded Health Canada License for its revolutionary EMSELLA® platform, reinforcing its leadership in pelvic health and intimate wellness.

FDA-cleared and Health Canada-licensed for the treatment of urinary incontinence in both men and women, Emsella now also holds an additional Health Canada license and CE-mark certification for enhancing sexual function in patients experiencing somatic sexual arousal disorders caused by weak pelvic floor muscles.

Backed by robust clinical outcomes, EMSELLA continues to redefine non-invasive care across pelvic health and sexual function. Key findings include:

Sexual Dysfunction Statistics:

• • 76% improvement in sexual satisfaction and desire¹
  • 60% improvement in orgasm quality¹
  • 37% improvement in maintaining erection during intercourse²
  • 48% improvement in pelvic muscle endurance³

When compared to other modalities, EMSELLA outperforms significantly:

• • 7x more effective than pelvic floor muscle training

"EMSELLA continues to surpass expectations—not just in treating incontinence but in restoring confidence, and overall quality of life," said David Chmel, CEO of BTL North America. "These expanded clearances and clinical outcomes validate what providers and patients have long experienced: EMSELLA delivers meaningful results in a way that's accessible, comfortable, and non-invasive."

Shari Caplan, MD, CCFP, FCFP, FAARM, a board-certified expert in functional, integrative , anti-aging, and intimate health said, "We're witnessing a complete shift in how pelvic and sexual health is approached. Patients are achieving results we used to think were only possible with surgery or years of therapy. EMSELLA has become a go-to solution in my practice for urinary control and sexual wellness for both men and women."

As the demand for intimate wellness treatments rises, EMSELLA remains uniquely positioned as an effective and versatile tool for addressing some of the most intimate and often under-discussed health concerns.

To learn more about EMSELLA, visit www.emsella.com.

About BTL

Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 350+ patents and over 580 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.

For more information, visit www.bodybybtl.com.

References:

¹ Hlavinka TC, Turcan P, Bader A (2019) The Use of HIFEM Technology in the Treatment of Pelvic Floor Muscles as a Cause of Female Sexual Dysfunction: A Multi-Center Pilot Study. J Women's Health Care 8: 455. doi:10.4172/2167-0420.1000455
² Brandeis J (2024) Improving Male Pelvic Health: Efficacy of HIFEM Muscle Stimulation for Urinary Function and Sexual Dysfunction in Men. Reprod Syst Sex Disord. 13:401.
³ Elena, S., Dragana, Z., Ramina, S., Evgeniia, A., & Orazov, M. (2020). Electromyographic Evaluation of the Pelvic Muscles Activity After High-Intensity Focused Electromagnetic Procedure and Electrical Stimulation in Women With Pelvic Floor Dysfunction. Sexual medicine, 8(2), 282–289. https://doi.org/10.1016/j.esxm.2020.01.004

Media Contact: samantha@samanthaslaven.com

BTL, the global leader in aesthetic and wellness technology, proudly announces the 6th annual National Emsculpt Week, taking place May 18–24, 2025. This year's celebration is bigger than ever. It combines provider recognition, real patient transformation, and community connection for an unforgettable week.

National Emsculpt Week spotlights the providers and patients who are embracing stronger bodies, functional wellness, and vibrant aging through Emsculpt^® and Emsculpt NEO^®. In 2025, BTL is taking things up a notch with a brand-new twist: a nationwide sweepstakes that will award free Emsculpt treatments to patients across the country. It's an exciting opportunity for people to jumpstart their wellness journeys and experience Emsculpt's muscle-building, confidence-boosting power firsthand.

The heart of the celebration is a national digital competition, offering exciting prizes for the most engaging provider posts across North America. Practices will post photos, reels, or stories showing their teams, patients, or favorite Emsculpt success moments. The most engaging and inspiring entries will win major prizes — including Emsculpt device applicators and the coveted Exion™ system with choice of applicator.

"This is more than just a celebration - it's a movement," said John Ferris, VP of Marketing at BTL. "By launching a national sweepstakes and spotlighting the incredible work of our providers, we're expanding access and empowering people to feel strong in their own skin. Emsculpt Week 2025 is about transformation, connection, and celebrating what's possible."

Since its debut in 2018, Emsculpt has led the category as the first and only non-invasive technology to use HIFEM^® to build muscle and sculpt the body. In 2020, the introduction of synchronized radiofrequency with Emsculpt NEO pushed results even further — delivering an average of 30% fat reduction and 25% more muscle in treated areas, with over 4 million treatments performed globally.

In 2024, BTL took the Emsculpt brand even further and introduced the next wellness revolution: The Functional Wellness. These new treatment protocols mark a major advancement in how the technology not only sculpts the body but also supports the patients with their day-to-day life — going beyond aesthetics to address mobility, flexibility, strength, muscle atrophy, range of motion, and expedited rehabilitation. A smarter, more complete approach to helping patients not just look better, but move and feel better too.

Whether you're a provider ready to share your success or a patient ready to experience what's next, National Emsculpt Week 2025 is your moment.

Learn more at www.bodybybtl.com.

About BTL:
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO^®, EMFACE^®, EXION™, EXOMIND™, EMSELLA^®, and others.

Media Contact: samantha@samanthaslaven.com

BTL, a global leader in medical and aesthetic innovation, announces the launch of EMFACE® Eye, the first non-invasive procedure designed to reverse under-eye aging by restoring muscle tone and soft tissue support at its foundation.

This launch comes as EMFACE surpasses one million treatments globally, making it the fastest-growing facial aesthetic technology to date. It follows a record-breaking Q1 2025, with 70% sales growth in North America, underscoring the momentum behind the brand and its cutting-edge portfolio.

"The response to EMFACE has been phenomenal," said David Chmel, CEO of BTL Industries. "Reaching the one million treatment mark and reporting our strongest Q1 in history is a testament to the power of BTL innovation - and the trust our providers place in us. With EMFACE Eye, we're once again pushing the boundaries of what's possible in non-invasive aesthetics."

EMFACE Eye addresses one of the most delicate, and previously hard-to-treat, areas: under-eye region. While traditional approaches have often relied on injectables or surgery to reduce puffiness, dark circles, and hollowness, EMFACE Eye offers a breakthrough complement. It tones the lower orbicularis oculi muscle, lifts soft tissue, and enhances periorbital support.

In a quick 20-minute, needle-free procedure, patients experience an average reduction of 1.4mL in eye bag volume, a 28% reduction in crow's feet, and a 64% decrease in dark circles. These clinically backed results require no downtime, making it a breakthrough for both providers and patients alike.

Dr. Melanie Palm, M.D., MBA, a respected cosmetic dermatologist in Solana Beach, CA, praised the advancement:

"As a cosmetic dermatologist with a sizeable injectable practice, this is exactly what I've been waiting for. The results include noticeable brightening of the under-eye and buttressing of the infraorbital fat pad, significantly reducing fat pseudo-herniation."

"Emface restores structure and function to the facial anatomy in the most natural way, so we can count on superior results that drive high patient satisfaction."

With the addition of Eye applicators, the EMFACE platform now enables full-face balancing across all anatomical thirds—from forehead lifting to jawline sculpting to under-eye enhancement. The platform supports a comprehensive, layered approach that pairs seamlessly with injectable treatments to deliver natural, harmonious result. 

About BTL

Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.

For more information, visit www.bodybybtl.com.

Media Contact – samantha@samanthaslaven.com

EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone—becoming the fastest procedure of its kind to surpass 1 million treatments worldwide in just under two years. This achievement cements EMFACE as the leading non-invasive facial procedure uniquely designed to treat both the skin and underlying muscles for a more youthful, lifted appearance.

Developed by BTL, a global leader in medical technology, EMFACE transformed the industry in 2022 as the first operator-independent procedure to non-invasively target facial muscles while simultaneously improving skin quality.

"The ability to stimulate elevator muscles allows us to lift facial features from within—something that was never possible before with injectables or traditional energy-based devices," said Dr. Yael Halaas, a facial plastic surgeon from NYC, USA.

With no needles, downtime, or discomfort, EMFACE has gained widespread recognition among both medical professionals and patients, driving its rapid adoption across the globe.

Innovation at the Forefront of Success

Over the past year, EMFACE has expanded its capabilities with the introduction of specialized submental and under-eye applicators, making the treatment even more versatile. The latest eye applicators received overwhelmingly positive feedback from attending medical experts upon their launch at the IMCAS World Conference in Paris in January 2025.

"EMFACE isn't just a procedure—it's a facial multiplatform that allows us to treat different areas based on each patient's unique needs. It's a game-changer for anyone looking for natural-looking facial rejuvenation," added Dr. Kyungkook Hong, a board-certified dermatologist from Seoul, Korea.

Global Expansion and Industry Impact

EMFACE continues to gain momentum, with more practitioners integrating it into their treatment offerings. Its ability to complement injectables makes it a key component of comprehensive facial rejuvenation plans, providing patients with non-invasive solution for enhanced results.

"Reaching 1 million treatments in just two years is a testament to EMFACE's groundbreaking technology and the value it brings to medical professionals," said Tomas Schwarz, CEO of BTL. "We remain committed to expanding this platform and further advancing non-invasive facial treatments in the years ahead."

For more information about EMFACE and its revolutionary technology, visit www.emface.com.

About BTL

Founded in 1993, BTL has grown to become one of the world's leading medical equipment manufacturers. With 500+ engineers and 3,000+ employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including intimate health and mental wellness. Among other brands, BTL's products include EMSCULPT NEO^®, EMFACE^®, EXION™, EMSELLA^®, EXOMIND™ as well as their proprietary HIFEM^®, HIFES™ and EXOTMS™ procedures. Please visit www.btlaesthetics.com for additional information.

BTL, a global leader in aesthetic, wellness and longevity technologies, is thrilled to announce a new partnership with Nava Health, a premier provider of integrative holistic health and wellness solutions. This collaboration brings BTL's cutting-edge devices—Emsculpt Neo, Emsella, Emface, and Exion—to Nava Health's national network of health and wellness centers.

The partnership reflects a shared commitment to enhancing lives through advanced, results-driven technologies and personalized care. BTL's innovative offerings perfectly complement Nava Health's medical weight loss programs, hormone replacement therapy, functional nutrition, and regeneration services. Together, the two companies provide a seamless integration of wellness, aesthetics, and longevity.

"Nava Health is dedicated to providing holistic solutions that help people look and feel their best," said Alexis Gaus, Director of Aesthetics. "Integrating BTL's groundbreaking devices allows us to expand our offerings and provide our clients with effective, non-invasive treatments for body sculpting, facial rejuvenation, pelvic health, and overall wellness. This partnership is a natural fit for our mission."

BTL's devices are renowned for their advanced technology and proven results:

• Emsculpt Neo: Combines HIFEM+ and radiofrequency to reduce fat and build muscle in a single treatment, making it a perfect complement to Nava's medical weight loss solutions.
• Emsella: Revolutionizes pelvic floor health with non-invasive electromagnetic stimulation.
• Emface: Offers a needle-free solution for facial rejuvenation by improving muscle tone and skin quality.
• Exion: Delivers powerful results for improved skin tone and texture with unmatched versatility.

"We're excited to partner with Nava Health, a leader in holistic health and wellness," said Nathan Lanham, Director of National Accounts at BTL. "This collaboration underscores our shared dedication to innovation and delivering life-changing results for clients. Nava Health's expertise and reach will help bring the benefits of Emsculpt Neo, Emsella, Emface, and Exion to even more people across the country. Together, we are redefining wellness, aesthetics, and longevity."

With this partnership, Nava Health clients will now have access to cutting-edge technologies that align with their health and wellness goals, ensuring a transformative experience that goes beyond aesthetics.

For more information about BTL and Nava Health, please visit www.bodybybtl.com and www.navacenter.com.

About BTL
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes EMSCULPT NEO^®, EMFACE^®, EXION^®, EMSELLA^®, and others. For more information, visit www.bodybybtl.com

About Nava Health
Nava Health is a leading provider of integrative holistic health and wellness solutions, specializing in medical weight loss, functional medicine, hormone therapy, and regenerative treatments. With a mission to help people feel their best at every stage of life, Nava Health delivers personalized care through an integrative approach.

BTL, the innovator in medical and aesthetic technologies, is thrilled to introduce the EXOMIND, powered by ExoTMS technology - a state-of-the-art, non-invasive brain stimulation treatment designed to improve mental and emotional well-being.

EXOMIND is FDA-cleared for depression in the United States, and also approved by Health Canada and CE-marked for treating depression, anxiety symptoms, obsessive-compulsive disorder and excessive eating disorders.

"EXOMIND technology demonstrates our commitment to wellness by delivering natural, innovative solutions that empower individuals to reach their full potential," emphasized Filip Donner, Company's director. He continued, "This patient-friendly therapy aligns with our vision of promoting holistic health. Unlike conventional treatments, it provides a natural approach to mental wellness, fostering brain resilience without the side effects often associated with pharmaceuticals."

"Our record-breaking Q4, with over $220 million in global sales, is a testament to the growing demand for BTL's cutting-edge solutions," Donner added. "This achievement affirms the trust and confidence customers place in our technologies."

EXOMIND offers a pioneering treatment that appeals to patients seeking seamless, drug-free alternatives. In clinical studies, patients appreciate EXOMIND's  comfortable, walk-in, walk-out sessions lasting under 30 minutes. The device's ease of use allows for quick integration into medical practices, including family medicine and internal medicine practices.

"For my practice, EXOMIND has been a game-changer," said Dr. JD McCoy. "The device is easy to operate and gives our patients a unique offering they truly value." 

"The majority of my patients are on some form of antidepressant medication. With EXOMIND, we now offer an alternative that enhances patient well-being and provides them with the freedom to manage their mental wellness without relying solely on medication," added Dr. Yael Halaas.

About BTL
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes EXOMIND™, EMSCULPT NEO®, EMFACE®, EXION™, EMSELLA®, and others. For more information, visit www.bodybybtl.com.